We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Presents Acusera Smart Controls Range

By LabMedica International staff writers
Posted on 03 Feb 2025
Print article
Image: The Acusera Smart QC line comprises controls for clinical chemistry, immunoassay, liquid cardiac and PTH (Photo courtesy of Randox)
Image: The Acusera Smart QC line comprises controls for clinical chemistry, immunoassay, liquid cardiac and PTH (Photo courtesy of Randox)

Randox Laboratories (Crumlin, UK) is highlighting its new Acusera Smart range of true third-party quality controls (QCs) at Medlab Middle East 2025 that offer complete test menu consolidation for laboratory internal quality control (IQC).

With approximately 70% of clinical decisions based on laboratory test results, the results provided must be accurate and reliable to prevent potential misdiagnosis or inappropriate treatment. Randox offers high-quality material that can help streamline procedures, whilst saving time and money for laboratories of all sizes and budgets. Randox offers an extensive product offering comprising third-party QCs & calibrators, interlaboratory data management, external quality assessment, calibration verification, and molecular IQC and EQA for infectious disease testing. Specializing in consolidation, the Acusera range of multi-analyte controls is designed to reduce the number of individual controls required to cover a lab’s test menu, ultimately reducing costs, preparation time, and storage space.

At the 2025 edition of Medlab Middle East, Randox is highlighting its Acusera Smart controls range that is designed to fit directly onto a wide range of test systems without the need to aliquot material, thereby streamlining the QC process by minimizing human error and optimizing workflow. The Acusera Smart Controls range comprises controls for clinical chemistry, immunoassay, liquid cardiac, and PTH. The Acusera Smart PTH Control is intended for use with IVD assays for the quantitative determination of Parathyroid Hormone in human serum and plasma. The Acusera Smart Liquid Cardiac Control is designed to cover a range of cardiac markers at clinical decision levels, eliminating the need for additional low-level controls at extra expenses. It is intended for use with IVD assays for the quantitative determination of 7 cardiac markers. The Acusera Smart Liquid Chemistry Control is intended for IVD use in the QC of diagnostic assays. Three clinically significant levels are available. Covering 98 analytes, the control enables effective consolidation and cost savings. The Acusera Smart Liquid Immunoassay Control is intended for IVD use to cover immunoassay testing in a single tube. The three clinically significant levels provided not only ensure accurate performance at key decision levels but also eliminate the need for additional controls, enabling greater consolidation and cost savings.

New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Human Chorionic Gonadotropin Test
Humasis hCG Combo
New
RNA Isolation Kits
RNeasy Plus Kits for RNA Isolation

Print article

Channels

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Pathology

view channel
Image: The OmicsFootPrint AI tool could open doors to new discoveries (Photo courtesy of Mayo Clinic)

Revolutionary AI Tool Transforms Disease Visualization

Genes serve as the body's blueprint, while proteins execute the instructions within those blueprints to maintain cell function. Occasionally, alterations in these instructions—known as mutations—can interfere... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.